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Disinfection by-products (DBPs) are a major
group of water contaminants, and their role in
causing adverse health outcomes has been sub-
ject to extensive epidemiologic and toxicologic
research and review (Bove et al. 2002;
Butterworth 2005; Butterworth and Bogdanffy
1999; Goebell et al. 2004; Graves et al. 2001;
Nieuwenhuijsen et al. 2000; Reif et al. 1996;
Tardiff et al. 2006; Villanueva et al. 2003).
Determination of safe levels in drinking water
has been subject to extensive debate, with a
wide range of acceptable levels set across the
industrialized world [Keegan et al. 2001;
National Health and Medical Research
Council (NHMRC) 2004; Rodriguez et al.
2004; U.S. Environmental Protection Agency
(EPA) 2004].
DBPs are formed by the reaction of chemi-
cal disinfectants with natural organic matter
(NOM) in water (Piccolo and Spiteller 2003;
Rook 1974; Thurman and Malcolm 1981).
The structure and quantity of NOM in water
sources—and hence the quantity and type of
DBPs formed—vary with geographic location
and season (Chen and Weisel 1998; Rodriguez
and Serodes 2001). DBPs commonly found in
drinking water include trihalomethanes
(THMs) [often measured as total trihalo-
methanes (TTHMs)], halogenated acetic acids
(HAAs), and halogenated acetonitriles
(HANs), although TTHMs have most often
been the focus of previous toxicologic and epi-
demiologic research. Research to date has
focused on the four regulated THMs: chloro-
form, bromoform, bromodichloromethane
(BDCM), and dibromochloromethane
(DBCM) (Da Silva et al. 2000). Toxicologic
studies have shown THMs may result in
adverse effects in laboratory animals, including
hepatotoxicity, nephrotoxicity, mutagenesis,
carcinogenicity, and adverse reproductive
effects (DeAngelo et al. 2002; Geter et al.
2004; International Life Science Institute
1995; Keegan et al. 1998; Landi et al. 1999;
Agency for Toxic Substances and Disease
Registry 1993).
Maternal DBP exposure has been linked to
an elevated risk for a range of reproductive out-
comes, including pregnancy loss, prematurity,
and low birth weight (Dodds et al. 1999, 2004;
Kallen and Robert 2000; King et al. 2000,
2005; Waller et al. 1998; Yang et al. 2000), as
well as neural tube defects (Dodds et al. 1999;
Dodds and King 2001; Hwang and Jaakkola
2003; Klotz and Pyrch 1999), cardiac defects
(Hwang et al. 2002), urogenital defects
(Magnus et al. 1999), and oral cleft defects
(Dodds et al. 1999). Table 1 summarizes the
most recent research on DBP exposure and
birth defects (BDs). Importantly, these studies
show signiﬁcant effects for several adverse birth
outcomes at levels of exposure to THMs that
have been observed in Australian metropolitan
areas, such as Perth (Dodds et al. 1999; King
et al. 2000).
Overall, ﬁndings relating to adverse effects
on reproductive health have been equivocal
and are often limited by crude exposure mea-
sures or implausible retrospective estimates of
exposure to DBPs. Because concentrations of
NOM and other chemical precursors in source
waters vary in both time and place, DBP levels
also fluctuate, complicating exposure assess-
ment in epidemiologic studies. Several authors
have indicated a number of concerns with
existing studies, particularly regarding their
failure to account for all exposure pathways or
the temporal and spatial variability in DBPs
within regions of water supply (Graves et al.
2001; Nieuwenhuijsen et al. 2000; Reif et al.
1996; Shaw et al. 2003). Also, in general, stud-
ies have not allowed for residential mobility,
use of alternative water sources for drinking
and bathing, or exposure to water sources out-
side the home. Dermal absorption of THMs is
particularly poorly estimated despite evidence
indicating that showering and other forms of
immersion are signiﬁcant sources of exposure
(Nieuwenhuijsen et al. 2002; Weisel and Jo
1996; Xu et al. 2002).
Given the ongoing controversy surround-
ing DBPs and adverse pregnancy outcomes,
especially regarding associated BDs, a precau-
tionary approach to DBP exposure during
pregnancy is somewhat justiﬁed. Most indus-
trialized countries have regulated the permitted
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BACKGROUND: By international standards, water supplies in Perth, Western Australia, contain high
trihalomethane (THM) levels, particularly the brominated forms. Geographic variability in these
levels provided an opportunity to examine cross-city spatial relationships between THM exposure
and rates of birth defects (BDs).
OBJECTIVES: Our goal was to examine BD rates by exposure to THMs with a highly brominated
fraction in metropolitan locations in Perth, Western Australia. 
METHODS: We collected water samples from 47 separate locations and analyzed them for total and
individual THM concentrations (micrograms per liter), including separation into brominated forms.
We classified collection areas by total THM (TTHM) concentration: low (< 60 µg/L), medium
(> 60 to < 130 µg/L), and high (≥ 130 µg/L). We also obtained deidentiﬁed registry-based data on
total births and BDs (2000–2004 inclusive) from post codes corresponding to water sample collec-
tion sites and used binomial logistic regression to compare the frequency of BDs aggregately and sep-
arately for the TTHM exposure groups, adjusting for maternal age and socioeconomic status.
RESULTS: Total THMs ranged from 36 to 190 µg/L. A high proportion of the THMs were bromi-
nated (on average, 92%). Women living in high-TTHM areas showed an increased risk of any BD
[odds ratio (OR) = 1.22; 95% conﬁdence interval (CI), 1.01–1.48] and for the major category of
any cardiovascular BD (OR = 1.62; 95% CI, 1.04–2.51), compared with women living in low-
TTHM areas.
CONCLUSIONS: Brominated forms constituted the signiﬁcant fraction of THMs in all areas. Small
but statistically signiﬁcant increases in risks of BDs were associated with residence in areas with
high THMs.
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http://dx.doi.org/ [Online 18 April 2008]levels of TTHM in drinking water, and many
of these limits are well below the 250 µg/L
level currently accepted in Australia (NHMRC
2004): Canada, 80 µg/L (Rodriguez et al.
2004); United States, 80 µg/L (U.S. EPA
2004); and the United Kingdom, 100 µg/L
(Keegan et al. 2001). By international stan-
dards, a number of Australian water supplies
continue to contain elevated DBP levels. The
water supplied to Perth, Western Australia, is
distinctive in several respects (Heitz et al.
2001). Depending on the suburb, the residen-
tial supply may be derived from groundwater
from aquifers underlying the city, surface water
from catchments along the eastern edge of the
city, or a mixture of both. Shallow groundwa-
ter resources in Perth contain both high levels
of the dissolved fraction of NOM [dissolved
organic carbon (DOC), 10–50 mg/L] and
highly variable concentrations of bromide
(0–2.2 mg/L), leading to a high fraction of
brominated DBP formation (Heitz et al.
2001). As a percentage of NOM, the DOC in
groundwater can range from 7% to 77%
(Wong et al. 2002). Historical records from
the city’s water authority, the Water
Corporation of Western Australia, indicate
that THM levels range from > 200 µg/L in
some water distribution areas to < 4 µg/L in
others. The geographic variation in these levels
provides an opportunity to examine the rela-
tionship between DBP exposure and adverse
outcomes of pregnancy within a discrete geo-
graphic area. In this study we compared the
prevalence of BDs in urban populations whose
residential water supplies contained markedly
different THM levels.
Materials and Methods
Study design. The study used a record-based
prevalence design based on the Western
Australia Midwives’ Notiﬁcation System and
Birth Defects Registry for the years
2000–2004 inclusive.
Water sampling and analysis. We col-
lected water samples at 47 separate locations
within the greater Perth metropolitan area in
Western Australia (Figure 1) from publicly
accessible taps in highly populated areas,
including drinking fountains, outdoor taps
close to picnic areas in public parks, and cold-
water taps located in public toilets, public
parks, and popular restaurants. We chose
sampling sites at locations where taps would
be frequently used, thereby limiting the stor-
age time of water in delivery pipe networks.
We collected the water samples on six sep-
arate occasions from April 2005 to March
2006, inclusive. We ﬂushed taps at each loca-
tion for 2 min before collection. We collected
water samples in 40-mL glass vials, each dosed
with the quenching agent sodium thiosulfate,
to prevent further THM formation once we
took samples. We stored the collected samples
on ice in an enclosed insulated carrier. During
each collection, we filled vials to maximum
level to prevent air bubbles upon sealing, to
prevent loss of THMs due to volatilization.
We collected samples from all 47 locations
within an 8-hr period on each sample day and
delivered them to the Chemistry Centre of
Western Australia for analysis at the comple-
tion of each sampling run.
We performed THM water analyses using
the “purge and trap” technique for sample
concentration and delivery, followed by gas
chromatography with mass spectrometric
detection (GC/MS) for the separation and
quantification of each of the four analytes
(U.S. EPA 2003). In this system, the sample is
purged with an unreactive gas and the analytes
trapped at a low temperature on an adsorbent
trap. The trap is then heated rapidly and the
desorbed compounds refocused at the head of
a GC chromatographic column for GC/MS
analysis. An internal standard is used to cor-
rect for slight differences in temperatures and
trapping conditions throughout the run. The
method is based on the U.S. EPA 5030C
(purge-and-trap for aqueous samples) method
(U.S. EPA 2003) and is accredited by the
Australian National Association of Testing
Authorities. Routine quality controls are per-
formed with each batch of samples, such as
replicate analyses, sample spiking, and blank
analyses. We analyzed each sample for TTHM
concentration (in micrograms per liter) and
for the four individual THMs chloroform,
bromoform, DBCM, and BDCM.
Data on births and BDs. We obtained
number of total births and BDs from post
codes corresponding to the water sample col-
lection sites for the years 2000–2004 inclusive
from the Western Australia Midwives’
Notification System and Birth Defects
Registry, respectively (Bower et al. 2007).
These two data sets form part of the compre-
hensive Western Australia Linked Database,
which systematically links available adminis-
trative health data within the state using
probabilistic matching of patient names and
other identifiers (Holman et al. 1999). We
obtained deidentified records on birth date,
post code of maternal residence at time of
birth, maternal age, socioeconomic status
code for the maternal residence at time of
birth (from linked census data), and the pres-
ence of BDs. The Western Australia Birth
Defects Registry uses multiple sources of case
ascertainment to identify BDs in live births,
stillbirths, and pregnancies terminated with
fetal abnormality. We did not include minor
malformations in our analyses unless they
were disﬁguring or required treatment. Cases
with only minor malformations account for
approximately 10% of all BDs registered. We
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Table 1. Review of principal associations and risk measures for DBP exposure and BDs.
Study design, region, reference Exposure range Defect type Risk estimate (95% CI)
Retrospective cohort, Canada (Dodds et al. 1999) High (> 100 µg/L) versus low (< 50 µg/L) THM levels Neural tube defects 2.96 (1.26–6.62)
Major cardiac defects 1.83 (0.97–3.92)
Oral cleft defects 3.17 (1.18–7.26)
Case–control, USA (Klotz and Pyrch 1999) High (> 40 µg/L) and low (< 5 µg/L) THMs Neural tube defects 2.10 (1.10–4.00)
High (> 3 µg/L) and low (< 0.5 µg/L) HANs Neural tube defects 1.30 (0.60–2.50)
High (> 35 µg/L) and low (< 3 µg/L) HAAs Neural tube defects 1.20 (0.50–2.60)
Retrospective cohort, Sweden (Kallen and Robert 2000) Chlorinated versus nonchlorinated water Major cardiac defects 1.10 (0.90–1.30)
Oral cleft defects 1.10 (0.80–1.60)
Retrospective cohort, Canada (Dodds and King 2001) High (> 20 µg/L) and low (< 5 µg/L) BDCM Neural tube defects 2.50 (1.20–5.10)
Major cardiac defects 0.30 (0.20–0.70)
Oral cleft defects 0.60 (0.20–0.90)
Cross-sectional, Norway (Hwang et al. 2002) Chlorination and color versus nonchlorinated All sentinel anomalies  1.18 (1.02–1.36)
Ventricular septal defects  1.81 (1.05–3.09)
Respiratory defects  1.89 (1.00–3.58)
Urinary tract defects  1.46 (1.00–2.13)
Case–control, Sweden (Cedergren et al. 2002) High (> 10 µg/L ) and low (< 5 µg/L) THMs Cardiac defects  1.30 (1.08–1.56)
Case–control, USA (Shaw et al. 2003) 50–74 µg/L THMs  Study 1: Neural tube defects  0.62 (0.26–1.50) 
Study 2: Neural tube defects  1.80 (0.26–1.50)
Oral cleft defects 1.00 (0.32–3.40)
Registry-based cohort, England and Wales  High (4 µg/L) versus low  Major cardiac defects 1.18 (1.00–1.39)
(Niewenhuijsen et al. 2008) (< 2 µg/L) bromoformdid not include terminations in the present
data, but these comprise a relatively small
proportion of all cases and have been rela-
tively constant for the past few years.
The Midwives’ Notification System is
statutory and is completed for all live births
and stillbirths of ≥ 20 weeks’ gestation or birth
weight ≥ 400 g. The Birth Defects Registry in
Western Australia has a high level of case
ascertainment (Bower et al. 2000, 2001).
A BD is deﬁned by the registry as a struc-
tural or functional abnormality that is present
at conception or occurs before the end of
pregnancy and is diagnosed by 6 years of age.
We coded each recorded BD using the British
Paediatric Association (BPA) International
Classification of Diseases, version 9, system
(British Paediatric Association 1979). We
investigated associations of DBPs with any
BD and also with the following major groups
of BDs: nervous system defects (BPA codes
74000–74299), cardiovascular defects (BPA
74500–74799), respiratory system defects
(BPA 74800–74899), gastrointestinal defects
(BPA 74900–75199), urogenital defects (BPA
75200–75399), musculoskeletal defects (BPA
75400–75699), and congenital anomalies of
integument (BPA 75700–75799). Because of
low case frequencies, we did not examine the
following groups separately: congenital anom-
alies of eye (BPA 74300–74399); congenital
anomalies of ear, face, and neck (BPA
74400–74499); chromosome defects (BPA
75800–75899); and all other defects (BPA
24390–24399, 25520–25529, 27000–27099,
27010, 27100–27199, 27700, 28220,
28240–28249, 28600–28620, 35900–35999,
75992, 77100, 77800).
Data analysis. We used STATA version
9.0 (StataCorp, College Station, TX, USA) for
data analysis. We classiﬁed collection sites and
post codes of maternal residence in three expo-
sure areas: low (TTHM < 60 µg/L), medium
(TTHM > 60 to < 130 µg/L), and high
(TTHM ≥ 130 µg/L). We the calculated
prevalence proportions for any BD and cate-
gories of major BDs for low, medium, and
high exposure groups. We calculated odds
ratios (ORs) and 95% confidence intervals
(CIs) for any BD and for categories of BDs
using binomial logistic regression models, and
calculated estimated risks for the medium and
high exposure areas using the low exposure
area as the comparison group. We adjusted all
estimates for maternal age at an individual
level using the deidentified and highly com-
plete case data from registry and midwives’
records and data on socioeconomic status
[using Socio-Economic Indexes for Areas
(SEIFA) coding (Australian Bureau of
Statistics 2001)]. SEIFA values are supplied by
post code and are calculated based on variables
including the proportion of families with high
incomes, people with a tertiary education, and
employees in skilled occupations; low values
indicate areas of disadvantage, and high values
indicate areas of advantage.
Results
TTHM levels. We averaged measurements for
each collection site over the six collection
dates, and identified all post codes as low,
medium, or high exposure as described in
“Materials and Methods.” Average TTHM
concentrations (±1 SD) for low, medium, and
high exposure areas were 54 ± 16.6 µg/L,
109.3 ± 28.9 µg/L, and 137 ± 24 µg/L, respec-
tively. Table 2 summarizes area THM levels,
including individual THM concentrations.
We also assessed the THM levels within each
assigned exposure category using analysis of
variance. The mean square errors and F-test
value (F = 204292.41; p < 0.00001) indicated
highly significant between-group differences
and relatively little within-group variability for
the specified category cutoff points.
Preliminary analysis of HAAs and HANs dur-
ing the December testing month showed very
low HAA and HAN concentrations by inter-
national standards (data not shown), so we did
not continue monitoring these compounds.
Prevalence of BDs. A total of 1,097 indi-
viduals with BDs among 20,870 live births
were recorded for the years 2000–2004 inclu-
sive in the study region. In each of the years
assessed, BD prevalence showed an increasing
Birth defects and disinfection by-products in Australia
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Figure 1. Map of the northern metropolitan area of Perth outlining individual sampling sites. Shaded areas
indicate water catchments.
Water sampling location
Low TTHM catchment
Medium TTHM catchment
High TTHM catchment
Indian Ocean
Approximately 5 kmtrend with higher categories of TTHM expo-
sure, with the exception of 2001 (Table 3).
Risk estimates. Women living in high-
TTHM areas at the time of birth of their
child showed an increased risk of any BD
(adjusted OR = 1.22; 95% CI, 1.01–1.48)
compared with women living in low-TTHM
areas. For individual BDs, we identiﬁed a sig-
niﬁcantly elevated OR for any cardiovascular
BD (adjusted OR = 1.62; 95% CI,
1.04–2.51) for women living in high-TTHM
areas compared with women living in low-
TTHM areas. Table 4 summarizes all results.
We evaluated maternal age as an independent
risk factor for BDs and a potential con-
founder in this analysis. Using maternal age
(in 5-year age strata) as a predictor, we calcu-
lated an OR of 1.03 (95% CI, 0.98–1.09) for
BD overall. Because average maternal age var-
ied slightly by region, we included it as an
individual-level covariate in the final model.
For the full model with TTHM exposures
included, we undertook restricted analysis on
mothers < 35 years of age to explore possible
impacts of advanced maternal age. ORs for
the restricted population were comparable
with the original analysis (data not shown).
We also conducted mixed-effect multilevel
analyses, but risk estimates did not substan-
tially differ from those using the original
regression models, with persistence of the sig-
nificant findings for overall BD and cardio-
vascular BD (data not shown).
Discussion
The results from this record-based prevalence
study indicate that women living in high-
TTHM areas in Perth at the time of birth of
their baby have a 22% greater risk of having a
baby with any BD. More speciﬁcally, classiﬁ-
cation in the high-exposure group is associ-
ated with an increased risk of 62% for having
a baby with a cardiovascular defect. In this
analysis, results for musculoskeletal and
urogenital defects are suggestive but non-
significant, with adjusted ORs of 1.48
(95% CI, 0.99–2.21) and 1.40 (95% CI,
0.98–1.99), respectively.
These findings suggest that there may
indeed be an area-related effect in Perth,
attributable to the city’s heterogeneous water
supply and quality. As discussed, the differen-
tial exposure patterns most likely relate to the
quantity of precursors in the source waters,
which display a rough latitudinal gradient.
The analyses of BD rates by year also suggest
that, except for 2001, the trend toward high
defect rates for higher THM levels has been
consistent. By international standards, a high
proportion of the THMs in the areas tested
were in the brominated form. Brominated
THMs are thought to possess a greater heath
risk compared with chloroform, and this
largely relates to differences in their metabo-
lism and toxicokinetics (Bull et al. 1995).
Reproductive and developmental toxicity has
been observed in particular with BDCM
(Bielmeier et al. 2001, 2003; Chen et al.
2004; Hunter 2002; Narotsky et al. 1997).
We assessed low, medium, and high water
consumption in a subpopulation of pregnant
women living in Perth in 2004–2005 (data
not shown). Based on the ingestion rates for
the surveyed population, an exposure model
estimated that residence in the highest
TTHM exposure group ingesting the highest
self-reported intake amount of 4.67 L/day will
expose a pregnant women to an equivalent of
3.85 µg TTHM/day. Using this estimation
technique, an estimated 3.47 µg TTHM/day
(90.1%) are brominated THMs (Chisholm K,
Cook A, Weinstein P, unpublished data).
These ﬁndings are compatible with a criti-
cal review that found evidence for a weak asso-
ciation between the presence of any BD and
TTHMs; the risk appeared highest for urinary
tract BDs speciﬁcally (Graves et al. 2001). A
review published in 2006 formed similar con-
clusions (Tardiff et al. 2006). Limited research
has been conducted on musculoskeletal
defects, with weak associatons reported (Graves
et al. 2001; Tardiff et al. 2006). The present
study showed no signiﬁcance for nervous sys-
tem defects, which contrasts with results from
Dodds and King (2001) that neural tube
defects were signiﬁcantly associated with expo-
sure to > 20 µg/L BDCM (OR = 2.5; 95% CI,
1.2–5.1), the same level of BDCM we found
in Perth water supplies (Table 2).
Recent literature suggests that lower
socioeconomic indices are often predictive of
higher BD rates (Carmichael et al. 2003;
Wasserman et al. 1998), but in this study our
regression models did not suggest an obvious
relationship between SEIFA, a composite
measure of socioeconomic deprivation avail-
able at census district levels (which contain,
on average, 225 households), and rates of
Chisholm et al.
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Table 2. Demographics and TTHM concentrations for exposure areas.
Area of TTHM exposure
Characteristic Low Medium High
No. of post codes included in exposure area 9 5 11
Average maternal age range (years) 25–29 30–34 30–34
SEIFAa
Range 945–1,026 1,002–1,100 873–1,082
Average 994.2 1033.6 982.1
Median 989.8 1028.0 997.6
Average THM concentration (µg/L)
TTHM 54.0 109.3 137.0
Chloroform 2.0 9.0 15.0
Bromoform 31.0 39.5 39.0
BDCM 5.0 19.5 29.0
DBCM 17.0 44.0 54.5
Median THM concentration (µg/L)
TTHM 51.0 115.0 140.0
Chloroform 1.0 8.2 11.0
Bromoform 29.0 38.0 40.0
BDCM 3.3 19.0 27.0
DBCM 16.0 44.5 53.0
Maximum individual site THM concentration (µg/L)
TTHM 140.0 160.0 190.0
Chloroform 5.2 19.0 52.0
Bromoform 54.0 66.0 78.0
BDCM 13.0 44.0 57.0
DBCM 28.0 72.0 81.0
Minimum individual site THM concentration (µg/L)
TTHM 36.0 39.0 61.0
Chloroform 1.0 1.0 2.8
Bromoform 20.0 6.3 9.6
BDCM 2.6 3.1 6.8
DBCM 10.0 12.0 18.0
25th percentile THM concentration (µg/L)
TTHM 42.0 93.25 120.0
Chloroform 1.0 6.20 8.1
Bromoform 24.0 33.50 20.0
BDCM 3.2 14.75 19.0
DBCM 13.0 34.75 46.0
75th percentile THM concentration (µg/L)
TTHM 62.0 130.0 150.0
Chloroform 3.15 10.25 16.0
Bromoform 34.0 47.25 53.0
BDCM 3.8 24.00 35.0
DBCM 18.0 53.25 62.0
aLow values indicate areas of disadvantage, and high values indicate areas of advantage.BDs in the suburbs examined. In this study,
we aggregated the SEIFA codes to calculate an
average by post code, which was the spatial
unit of BD data (Table 2 summarizes the
number of post codes per exposure area). In
relation to the exposure, areas with higher
socioeconomic (SEIFA) scores commonly fell
within the highest THM category; that is,
mothers resident in the more afﬂuent suburbs
were either just as or more likely to be highly
exposed to THMs compared with those in
socioeconomically deprived suburbs (Table
2). This suggests that socioeconomic factors
themselves are not a plausible explanation for
the observed ﬁndings, and—if anything—the
spatial relationship between high socioeco-
nomic status and low quality water in the
study area may have tended to attenuate the
risk estimate. The particular hospital or clinic
used for delivery is also unlikely to be a source
of error because the system for collecting BD
data is consistent across clinics and routinely
audited. In addition, differential maternity/
obstetric hospital use by location of residence
(and hence exposure) is unlikely given the
small number of such hospitals in the catch-
ment areas used for the study. We assessed
potential confounding by maternal age, but it
was not a signiﬁcant predictor of BDs in most
full exposure models (including those with
positive findings for THM exposure). The
average age of the mothers varied slightly by
TTHM exposure region, but we adjusted for
possible confounding effects at the individual
level using the deidentiﬁed case data.
We acknowledge several limitations in this
analysis. Because we used an ecologic exposure
measure in this study, the use of residential
TTHMs to assign individual exposure raises
the possibility of exposure misclassification.
For example, women may not have lived in
the area at the critical time window relevant to
formation of BDs (at conception and first
trimester for most BDs). A survey of 78 preg-
nant women in Perth that we conducted in
2004–2005 (data not included) found that
15.6% of participants reported moving resi-
dence during their pregnancy. This ﬁnding is
similar to recent data reported from a cohort
of 584 pregnant women recruited from within
Sydney between 2004 and 2006. Of these
women, 18% moved residences, although this
estimate includes residential movement up to
6 months postpartum (Raynes-Greenow et al.
2007). If exposure misclassification has
occurred as a result of migration, it is likely to
be nondifferential, so risk estimates presented
in this study may be overly conservative.
Because we have not accounted for individual
exposure assessment, we have not taken into
account contact with other disinfected water
sources (e.g., through swimming and work-
related exposures). However, a small survey of
54 pregnant women in metropolitan Perth we
conducted in 2004 (data not shown) indicated
that 68.5% consumed tap water during their
pregnancy, suggesting that bottled water is not
a commonly used alternative among this pop-
ulation. Rainwater is not commonly used in
Western Australia. A total of 96.3% of the
women interviewed used publicly supplied
water for showering and bathing, indicating
that contact with the town supply remains rel-
evant given that inhalation and dermal absorp-
tion are important routes of exposure to
THMs (Meek et al. 2002; Weisel and Chen
1994; Xu et al. 2002; Xu and Weisel 2005).
The measurements used were not taken
during the same time period as the health
outcome, and limited public availability of
complete TTHM levels in Perth precludes the
reliable use of historical data. The limited
DBP data published for the Perth region is
consistent with our exposure estimates, but
this historical data set consists of, on average,
four samples (or fewer) per year and covers
only half of the suburbs that we tested in our
study (Water Corporation of Western
Australia 2002–2003). Many factors are
known to affect DBP formation, including
pH, contact time, temperature, concentration
and properties of NOM, concentration of
both chlorine and residual chlorine, and
concentration of bromide, and these may be
Birth defects and disinfection by-products in Australia
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Table 3. Number of births, BDs, and BD prevalence for TTHM exposure areas for births within the Perth
metropolitan area, 2000–2004 inclusive.
Year
TTHM exposure group Births and BDs 2000 2001 2002 2003 2004 2000–2004
Low (< 60 µg/L) TB (n) 518 556 572 639 659 2,944
BD (n) 3 13 11 9 2 42 91 3 4
BDP (%) 6.4 5.6 3.3 3.8 4.4 4.6
Medium (> 60 to < 130 µg/L) TB (n) 958 934 930 945 981 4,748
BD (n) 5 86 03 5 4 24 02 3 5
BDP (%) 6.4 6.4 3.8 4.4 4.1 5.0
High (≥ 130 µg/L) TB (n) 2,638 2,666 2,593 2,557 2,724 13,178
BD (n) 174 149 146 127 132 728
BDP (%) 7.1 5.6 5.6 5.0 4.8 5.5
Abbreviations: BDP, BD prevalence for exposure area; TB, total number of births for exposure area.
Table 4. ORs (95% CIs) for the association between TTHM exposure and any BD or individual BD,
2000–2004 inclusive.
Birth outcomea Case numberb Adjusted OR (95% CI)c
Any BD
Low 134 1.00
Medium 235 0.98 (0.75–1.28)
High 728 1.22 (1.01–1.48)*
Cardiovascular (BPA 74500–74799)
Low 24 1.00
Medium 55 1.00 (0.55–1.81)
High 181 1.62 (1.04–2.51)*
Musculoskeletal (BPA 75400–75699)
Low 29 1.00
Medium 53 1.05 (0.60–1.83)
High 200 1.48 (0.99–1.21)
Gastrointestinal (BPA 74900–75199)
Low 11 1.00
Medium 24 1.27 (0.55–2.96)
High 66 1.20 (0.63–2.30)
Urogenital (BPA 75200–75399)
Low 40 1.00
Medium 76 1.09 (0.68–1.77)
High 235 1.40 (0.98–1.99)
Nervous system (BPA 74000–74299)
Low 6 1.00
Medium 15 1.78 (0.55–5.80)
High 38 1.08 (0.41–2.85)
Respiratory system (BPA 74800–74899)
Low 2 1.00
Medium 3 1.06 (0.13–8.87)
High 12 0.88 (0.18–4.18)
Integument congenital anomalies (BPA 75700–75799)
Low 13 1.00
Medium 15 0.91 (0.36–2.33)
High 8 0.95 (0.49–1.83)
aLow, < 60 µg/L; medium, > 60 to < 130 µg/L; high, ≥ 130 µg/L. bTotal births for each exposure area: low, 2,944; medium,
4,748; high, 13,178. cAdjusted for maternal age and socioeconomic status.
*p < 0.05.subject to variation seasonally and from year
to year (Krasner et al. 1989; Singer 1993). We
observed elevated THM levels during the
summer months, and we consistently recorded
the highest levels at sites within the high-
TTHM regions. Because the increases and
decreases in THM levels occurred concur-
rently across all regions by season, the differ-
ences between average levels observed within
low, medium, and high regions remained con-
sistent. For conﬁdentiality, birth and BD data
were not available by date of birth, so we
could not subclassify based on season.
Finally, we extracted BD data for this study
in 2007, so for children born after 2001,
defects not recognized until later in their lives
have yet to be ascertained and included in the
registry. However, there is no reason to sup-
pose that this process would be differential by
post code, and any incomplete ascertainment
for more recent years of birth would be similar
for all study locations. Western Australian also
has only one centralized Birth Defects Registry,
with consistent ascertainment and quality
assurance protocols, making substantial vari-
ability by region unlikely, particularly within
the metropolitan area.
It is reasonable to argue that public health
beneﬁts from chlorination in terms of micro-
biologic safety prevail over the conﬂicting evi-
dence of potential health risks associated with
DBP exposure (Tardiff et al. 2006). However,
in Australia and other centers that permit ele-
vated DBP levels, parts of the population are
exposed to levels higher than those considered
prudent by other industrialized countries. We
suggest that national or regional authorities
that permit higher TTHM levels may need to
reexamine their water quality guidelines to
reduce avoidable adverse birth outcomes. If a
true elevation in risk is conﬁrmed, a massive
and costly engineering “fix” to reduce DBP
exposure may not necessarily be warranted.
Public health interventions in problem
regions of low water quality and availability
may be as simple as recommending and/or
providing bottled water for pregnant women
or ensuring adequate filtration of contami-
nants before consumption.
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